SPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer
Figure 3
SPARC expression in stage II and III CRC using TMAs.
(A) The SPARC to vimentin ratio was significantly greater in CRC tissue compared to normal colonic tissue. (B) No difference in SPARC expression was observed between stage II and III CRC. (C) SPARC was significantly greater in patients with a good disease outcome in stage II CRC, but not in (D) stage III CRC. Each dot represents one patient and the bars represent the median value ± SEM.